Detalles de la búsqueda
1.
Feasibility evaluation of radiotherapy positioning system guided by augmented reality and point cloud registration.
J Appl Clin Med Phys
; 25(4): e14243, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38229472
2.
Effective doses of midazolam oral solution for the prevention of preoperative anxiety in paediatric patients.
Int J Paediatr Dent
; 2024 Jan 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-38243663
3.
Pembrolizumab plus Chemotherapy in Metastatic Non-Small-Cell Lung Cancer.
N Engl J Med
; 378(22): 2078-2092, 2018 May 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-29658856
4.
Patient-reported outcomes following pembrolizumab or placebo plus pemetrexed and platinum in patients with previously untreated, metastatic, non-squamous non-small-cell lung cancer (KEYNOTE-189): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial.
Lancet Oncol
; 21(3): 387-397, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-32035514
5.
A model that predicts a real-time tumour surface using intra-treatment skin surface and end-of-expiration and end-of-inhalation planning CT images.
Br J Radiol
; 97(1157): 980-992, 2024 May 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-38547402
6.
Construction of pseudorabies virus variant attenuated vaccine: codon deoptimization of US3 and UL56 genes based on PRV gE/TK deletion strain.
Front Microbiol
; 14: 1248573, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37881250
7.
Pembrolizumab as Second-Line Therapy for Advanced Hepatocellular Carcinoma: Longer Term Follow-Up from the Phase 3 KEYNOTE-240 Trial.
Liver Cancer
; 12(4): 309-320, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37901200
8.
ALBI score and outcomes in patients with hepatocellular carcinoma: post hoc analysis of the randomized controlled trial KEYNOTE-240.
Ther Adv Med Oncol
; 13: 17588359211039928, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34616489
9.
MiR-142-3p inhibits adipogenic differentiation and autophagy in obesity through targeting KLF9.
Mol Cell Endocrinol
; 518: 111028, 2020 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32911017
10.
Use of Prohibited Medication, a Potentially Overlooked Confounder in Clinical Trials: Omarigliptin (Once-weekly DPP-4 Inhibitor) Monotherapy Trial in 18- to 45-year-olds.
Clin Ther
; 39(10): 2024-2037, 2017 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-28923291
11.
A randomized, double-blind, non-inferiority trial evaluating the efficacy and safety of omarigliptin, a once-weekly DPP-4 inhibitor, or glimepiride in patients with type 2 diabetes inadequately controlled on metformin monotherapy.
Curr Med Res Opin
; 33(10): 1861-1868, 2017 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-28548024
12.
Final analysis of a randomised trial comparing pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory advanced melanoma.
Eur J Cancer
; 86: 37-45, 2017 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-28961465
Resultados
1 -
12
de 12
1
Próxima >
>>